EUPRAXIA PHARMACEUTICALS INC. (EPRX) Total liabilities 2023–2025
EUPRAXIA PHARMACEUTICALS INC. (EPRX) total liabilities at each fiscal year-end, per SEC filings.
$5.7MFY2025 · since FY2023: $19.4M → $5.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.7M | +83.8% |
| FY2024 | $3.1M | -84.0% |
| FY2023 | $19.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More EPRX financial trends
EPRX RevenueEPRX Net incomeEPRX Net marginEPRX Gross profitEPRX Gross marginEPRX Operating incomeEPRX Operating marginEPRX Operating cash flowEPRX Free cash flowEPRX Capital expendituresEPRX Return on equityEPRX Stock buybacksEPRX Dividends paidEPRX Total assetsEPRX Shareholders’ equityEPRX overview →